Nektar Therapeutics (NKTR) Other Working Capital Changes (2016 - 2025)
Historic Other Working Capital Changes for Nektar Therapeutics (NKTR) over the last 16 years, with Q3 2025 value amounting to $618000.0.
- Nektar Therapeutics' Other Working Capital Changes fell 8272.78% to $618000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $8.0 million, marking a year-over-year increase of 20506.09%. This contributed to the annual value of $4.2 million for FY2024, which is 21685.74% up from last year.
- According to the latest figures from Q3 2025, Nektar Therapeutics' Other Working Capital Changes is $618000.0, which was down 8272.78% from -$985000.0 recorded in Q2 2025.
- In the past 5 years, Nektar Therapeutics' Other Working Capital Changes registered a high of $10.8 million during Q3 2021, and its lowest value of -$6.2 million during Q1 2021.
- For the 5-year period, Nektar Therapeutics' Other Working Capital Changes averaged around $98684.2, with its median value being $618000.0 (2025).
- In the last 5 years, Nektar Therapeutics' Other Working Capital Changes tumbled by 16014.71% in 2022 and then surged by 51045.08% in 2025.
- Nektar Therapeutics' Other Working Capital Changes (Quarter) stood at $3.4 million in 2021, then tumbled by 160.15% to -$2.0 million in 2022, then surged by 142.4% to $867000.0 in 2023, then soared by 179.82% to $2.4 million in 2024, then crashed by 74.53% to $618000.0 in 2025.
- Its Other Working Capital Changes stands at $618000.0 for Q3 2025, versus -$985000.0 for Q2 2025 and $6.0 million for Q1 2025.